Author:
Korevaar Steven,Tennakoon Ruwan,Page Mark,Brotchie Peter,Thangarajah John,Florescu Cosmin,Sutherland Tom,Kam Ning Mao,Bab-Hadiashar Alireza
Abstract
AbstractProstate cancer (PCa) is the second most frequent type of cancer found in men worldwide, with around one in nine men being diagnosed with PCa within their lifetime. PCa often shows no symptoms in its early stages and its diagnosis techniques are either invasive, resource intensive, or has low efficacy, making widespread early detection onerous. Inspired by the recent success of deep convolutional neural networks (CNN) in computer aided detection (CADe), we propose a new CNN based framework for incidental detection of clinically significant prostate cancer (csPCa) in patients who had a CT scan of the abdomen/pelvis for other reasons. While CT is generally considered insufficient to diagnose PCa due to its inferior soft tissue characterisation, our evaluations on a relatively large dataset consisting of 139 clinically significant PCa patients and 432 controls show that the proposed deep neural network pipeline can detect csPCa patients at a level that is suitable for incidental detection. The proposed pipeline achieved an area under the receiver operating characteristic curve (ROC-AUC) of 0.88 (95% Confidence Interval: 0.86–0.90) at patient level csPCa detection on CT, significantly higher than the AUCs achieved by two radiologists (0.61 and 0.70) on the same task.
Publisher
Springer Science and Business Media LLC
Reference29 articles.
1. Bray, F. et al. Global cancer statistics 2018: globocan estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: Cancer J. Clin. 68, 394–424. https://doi.org/10.3322/caac.21492 (2018).
2. Siegel, R. L., Miller, K. D. & Jemal, A. Cancer statistics, 2017. CA Cancer J. Clin. 67, 7–30. https://doi.org/10.3322/caac.21387 (2017).
3. Prostate cancer | causes, symptoms & treatments, cancer.org.au, 2020 (Accessed 15 Dec 2020); https://www.cancer.org.au/cancer-information/types-of-cancer/prostate-cancer.
4. Schröder, F. H. et al. Screening and prostate cancer mortality: results of the european randomised study of screening for prostate cancer (ERSPC) at 13 years of follow-up. The Lancet 384, 2027–2035 (2014).
5. Hassanzadeh, E. et al. Prostate imaging reporting and data system version 2 (PI-RADS v2): a pictorial review. Abdom. Radiol. 42, 278–289 (2017).
Cited by
8 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献